Testicular function in young men treated in prepubertal period for childhood malignancy;Czynność gonad u chłopców i młodych mȩżczyzn leczonych przed pokwitaniem z powodu choroby nowotworowej

Pediatric Endocrinology, Diabetes and Metabolism

Volumn 14, Issue 2, 2008, Pages 93-98

  Krawczuk Rybak, Maryna ^a,e   Solarz, Elzbieta ^a   Wysocka, Jolanta ^b   Wojtkowska, Małgorzata ^b   Matysiak, Michał ^c   Gadomski, Artur ^c   Kazanowska, Bernarda ^d   Sȩga Pondel, Dorota ^d  

^a Klinika Onkologii Dzieci cej UM W Bia ymstoku

^b Zakład Pediatrycznej Diagnostyki Laboratoryjnej UM W Białymstoku ^*

^c Medical University of Warsaw Katedra i Klinika Pediatrii Hematologii i Onkologii   (Poland)

^d Katedra I Klinika Transplantacji Szpiku Hematologii I Onkologii Dzieciecej AM we Wrocawiu

^e AM   (Poland)

Author keywords

Childhood malignacies; Gonadotoxicity; Inhibin B; Late effects

Indexed keywords

ANTINEOPLASTIC AGENT; FOLLITROPIN; INHIBIN B; LUTEINIZING HORMONE; TESTOSTERONE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CANCER SURVIVOR; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; CONTROLLED STUDY; FOLLITROPIN BLOOD LEVEL; HODGKIN DISEASE; HUMAN; LUTEINIZING HORMONE BLOOD LEVEL; MALE; NONHODGKIN LYMPHOMA; PREPUBERTY; SOLID TUMOR; TESTIS DISEASE; TESTIS FUNCTION; TESTIS SIZE; TESTOSTERONE BLOOD LEVEL;

EID: 84904848775     PISSN: 1234625X     EISSN: 20838441     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Bleyer W.A.: The impact of childhood cancer on the United States and the world. Cancer, 1990, 40, 355-367.
2. Relander T., Cavallin-Stahl E., Garwicz S. i wsp.: Gonadal and sexual function in men treated for childhood cancer. Med. Pediatr. Oncol., 2000, 35, 52-63.
3. Brougham M., Wallace W.H.B.: Subfertility in children and young people treated for solid and hematological malignancies. Br. J. Haematol., 2005, 131, 143-155.
4. Crofton P.M., Evans A.E.M., Groome N.P. i wsp.: Inhibin B in boys from birth to adulthood: relationship with age, pubertal stage, FSH and testosterone. Clin. Endocrinol., 2002, 56, 215-221.
5. Cicognani A., Cacciari E., Pasini A. i wsp.: Low serum inhibin B level as a marker of testicular damage after treatment for a childhood malignancy. Eur. J. Pediatr., 2000, 159, 103-107.
6. Kumanov P., Nandipati K., Tomova A., Agrawal A.: Inhibin B is a better marker of spermatogenesis than hormones in the evaluation of male factor infertility. Fertil. Steril., 2006, 86, 332-338.
7. Kenney L.B., Laufer M.R., Grant F.D. i wsp.: High risk of infertility and long term gonadal damage in males treated with high dose cyclophosphamide for sarcoma during childhood. Cancer, 2001, 91, 613-621.
8. Mustieles C., Munoz A., Alonso M. i wsp.: Male gonadal function after chemotherapy in survivors of childhood malignancy. Med. Pediatr. Oncol., 1995, 24, 347-351.
9. Arush M.W.B., Solt I., Lightman A. i wsp.: Male gonadal function in survivors of childhood Hodgkin and non-Hodgkin lymphoma. Pediatr. Hematol. Oncol., 2000, 17, 239-245.
10. Kelnar C.J.H., McKinnell C., Walker M. i wsp.: Testicular changes during infantile "quiescence" in the marmoset and their gonadotropin dependence: a model for investigating susceptibility of the prepubertal human testis to cancer therapy? Hum. Reprod., 2002, 5, 1367-1378.
11. Crofton P.M., Thomson A.B., Evans A.E.M. i wsp.: Is inhibin B a potential marker of gonadotoxicity in prebubertal children treated for cancer? Clin. Endocrinol., 2003, 58, 296-301.
12. Sklar C.A., Robinson L.L., Nesbit M.E. i wsp.: Effects of radiation on testicular function in long-term survivors of childhood acute lymphoblastic lymphoma leukaemia: a report from the Children Cancer Study Group. J. Clin. Oncol., 1990, 8, 1981-1987.
13. Petersen P.M., Andersson A.M., Rorth M. i wsp.: Undetectable inhibin B serum levels in men after testicular irradiation. J. Clin. Endocrinol. Metab., 1999, 84, 213-215
14. Darzy K.H., Gleeson H.K., Shalet S.M.: Growth and neuroendocrine conseqences w.: Wallace H, Green D: Late effects of childhood cancer. Wyd. Arnold, London 2004, 198-211.
15. Byrne J., Fears T.R., Mills J.L. i wsp.: Fertility of long-term male survivors of acute lymphoblastic leukemia diagnosed during childhood. Pediatr. Blood Cancer, 2004, 42, 364-372.
16. Rueffer U., Breuer K., Josting A. i wsp.: Male gonadal dysfunction in patients with Hodgkin's disease prior to treatment. Ann. Oncol., 2001, 12, 1307-1311.
17. Heikens J., Behrendt H., Adriaanse R., Berghout A.: Irreversible gonadal damage in male survivors of pediatric Hodgkin's disease. Cancer, 1996, 78, 2020-2024.
18. Hobbie W.L., Ginsberg J.P., Ogle S.K. i wsp.: Fertility in males treated for Hodgkins disease with COPP/ABV hybrid. Pediatr. Blood Cancer, 2004, 44, 193-196.
19. Austin S.M., Robaire B., Hales B.F., Kelly S.M.: Paternal cyclophosphamide exposure causes decreased cell proliferation in cleavage-stage embryos. Biol. Reprod., 1994, 50, 711.
20. Krawczuk-Rybak M., Solarz E., Gadomski A. i wsp.: Ocena funkcji spermatogenezy i steroidogenezy u młodych mȩżczyzn leczonych w dzieciństwie z powodu chłoniaków nieziarniczych i ziarnicy złośliwej. Med. Wieku Rozwoj., 2006, 3, 624-630.
21. Schrader M., Heicappell R., Muller M. i wsp.: Impact of chemotherapy on male fertility. Oncologie, 2001, 24, 326-330.
22. Uderzo C., Locasciulli A., Marzorati R. i wsp.: Correlation of gonadal function with histology of testicular biopsies at treatment discontinuation in childhood acute leukemia. Med. Pediatr. Oncol., 1984, 12, 97-100.
23. Loverro G., Vicino M., Santoro N. i wsp.: Gonadal function after chemotherapy for acute lymphoblastic leukemia. Minerva Ginecol., 1996, 48, 193-197.
24. Soriano G.L., Munoz C.M.T., Pozo R.J. i wsp.: Changes in gonadal function in postpubertal male survivors of acute lymphoblastic leukemia and Hodgkin's disease. An. Esp. Pediatr., 2000, 53, 318-323.
25. Bordallo M.A., Guimaraes M.M., Pessoa C.H. i wsp.: Decreased serum inhibin B/FSH as a marker of Sertoli cell function in male survivors after chemotherapy in childhood and adolescence. J. Pediatr. Endocrinol. Metab., 2004, 17, 879-887.
26. Tsatsoulis A., Shalet S.M., Morris I.D., de Kretser D.M.: Immunoactive inhibin as a marker of Sertoli cell function follow cytotoxic damage to the human testis. Horm. Res., 1990, 34, 254-258.